Skip to main content
PLOS One logoLink to PLOS One
. 2022 Dec 6;17(12):e0278657. doi: 10.1371/journal.pone.0278657

Lower limb muscle fatigue after uphill walking in children with unilateral spastic cerebral palsy

I Moll 1,2,3,*, J M N Essers 2, R G J Marcellis 4, R H J Senden 4, Y J M Janssen-Potten 5,6, R J Vermeulen 1,3, K Meijer 2
Editor: Xin Ye7
PMCID: PMC9725134  PMID: 36473000

Abstract

Fatigue during walking is a common complaint in cerebral palsy (CP). The primary purpose of this study is to investigate muscle fatigue from surface electromyography (sEMG) measurements after a treadmill-based fatigue protocol with increasing incline and speed in children with CP with drop foot. The secondary purpose is to investigate whether changes in sagittal kinematics of hip, knee and ankle occur after fatigue. Eighteen subjects with unilateral spastic CP performed the protocol while wearing their ankle-foot orthosis and scored their fatigue on the OMNI scale of perceived exertion. The median frequency (MF) and root mean square (RMS) were used as sEMG measures for fatigue and linear mixed effects model were applied. The MF was significantly decreased in fatigued condition, especially in the affected leg and in the tibialis anterior and peroneus longus muscle. The RMS did not change significantly in fatigued condition, while the OMNI fatigue score indicated patients felt really fatigued. No changes in sagittal kinematics of hip, knee and ankle were found using statistical non-parametric mapping. In conclusion, the current fatigue protocol seems promising in inducing fatigue in a population with CP with drop foot and it could be used to expand knowledge on muscle fatigue during walking in CP.

Background

Cerebral palsy (CP) describes a group of permanent disorders of the development of movement and posture causing activity limitations, resulting from an injury in the developing central nervous system [13]. CP is the most common cause of motor disability in children (1.8–2.1 children per 1000 births) and most patients (±85%) experience spasticity [46]. During growth, the muscle length can fall short due to spasticity and bone deformities can develop [7]. As a consequence, abnormal gait patterns [8] with wasting of mechanical energy and co-activation and co-contractions of muscles develop. This makes walking less energy efficient in children with CP [9, 10], even in Gross Motor Function Classification System (GMFCS) level I [11, 12].

Children with CP often experience fatigue, restricting their activities and participation [13]. Several definitions of fatigue exist. Kluger et al. defines ‘fatigue’ as a subjective sensation, and ‘fatigability’ as objective, exercise-induced changes in performance [14]. Van Geel et al. defines fatigability as ‘state fatigue’: a form of fatigue that changes in response to tasks and circumstances, with a performance (objective) component and a perceived (subjective) component [15]. Physiologically, fatigability can be divided in two components: peripheral fatigue and central fatigue [16]. Peripheral fatigue is a loss in the force-generating capacity due to processes distal to the neuromuscular junction. Contributing factors include the muscles, glycogen storage, energy depletion and pathologies affecting the muscle functions (e.g. myasthenia gravis, Guillain-Barré syndrome) [14, 16]. Central fatigue is a progressive exercise-induced reduction in voluntary activation. Metabolic and structural lesions that disturb the normal process of activation in pathways between the basal ganglia, thalamus, limbic system and higher cortical centers contribute to the pathogenesis of central fatigue [17]. Children with CP are found to be less fatigue resistant than typically developing adolescents when testing submaximal contractions [18]. They have lower maximal muscle strength compared to typically developing children [19] and difficulties activating their muscles fully due to recruitment problems [20], as proved by lower activation levels during maximal voluntary contractions [21]. However, this means on the other side that children with CP potentially have a larger force reserve which can coincide with less peripheral fatigue [19, 20, 22]. As most activities in daily life are performed at submaximal strength, children with CP should probably be considered as being more fatigable [16]. Besides activation levels and force reserve, muscle morphology and structure can play a role in fatigue in CP. Several alterations in the latter have been described in CP, including reduced volume of muscles, shorter fascicle length and aberrant acetylcholine receptor localization [20]. Also, it has been reported that children with CP have more type I muscle fibers, which are slow but more fatigue resistant than type II fibers [23, 24].

Muscle fatigue can be assessed via surface electromyography (sEMG), measuring muscle activity using characteristics such as the root mean square (RMS) value to quantify the amplitude and the median frequency (MF) to quantify the spectral content of the sEMG signal [25]. These properties of the sEMG signal change during fatigue [26]. During muscle contractions metabolic products, such as lactic acid, are produced. Increased concentrations of lactic acid decreases the intracellular pH and consequently, the muscle fiber conduction velocity and MF decreases [26]. When muscles fatigue, the force-generating capacity decreases. Consequently, the neural drive increases to activate more motor units to maintain the required force level and this leads to an increase in RMS [16, 27]. Besides the decrease in conduction velocity, remaining activity of slow muscle fibers contributes to the decrease in MF and increase in RMS in fatigue [26].

Although fatigue is a frequently reported complaint in CP, little is known about measurements of fatigue during daily life activities such as walking [13]. Fatigue is mostly studied in (sub)maximal static contractions, which are less representative for daily life activities [16]. Knowledge about muscle fatigue during walking in CP is relevant because it could lead to new therapy insights to improve muscle endurance and finally activities in daily life. A few studies on fatigue during walking have been performed, reporting that more sEMG signs of muscle fatigue are present in the affected lower leg of children with CP during five minutes walking at self-selected speed compared to the non-affected leg or healthy children [16]. Parent et al. reported sEMG signs of muscle fatigue in the gluteus medius and rectus femoris muscle in subjects with jump gait and crouch gait respectively during a six minute walking exercise at self-selected speed [2830]. The aforementioned studies included patients with GMFCS level I-III. However, it is questionable how fatiguing it is to walk a few minutes at comfortable walking speed, especially for physically well-performing patients (GMFCS level I or II). We therefore developed a so called ‘fatigue protocol’ for children with CP with drop foot, to measure muscle fatigue after uphill and fast walking. These patients usually have a mild motor impairment (GMFCS level I) and can walk relatively well. Therefore, such a fatigue protocol might be more effective in inducing fatigue than walking at a comfortable speed at level ground. It should be taken into account that due to the uphill walking, it is possible that certain muscles will be relatively more fatigued, such as the hip- and knee flexors. It has been described that during uphill walking, the contribution to positive power decreases for the ankle and increases for the hip [31].

Besides analyzing changes in sEMG signals, it is important to analyze the impact of muscle fatigue on gait kinematics [28]. Parent et al. reported kinematic changes such as increased knee flexion in jump gait and crouch gait in children with CP in fatigued condition [28, 29]. No reports on kinematic changes due to fatigue in drop foot gait were found.

The aim of this study is to investigate whether the sEMG shows signs of fatigue (i.e. lower MF and higher RMS) after the fatigue protocol (compared to before) in children with CP with drop foot. The secondary aim is to investigate whether changes in sagittal plane kinematics of hip, knee and ankle occur after the fatigue protocol. We hypothesize that a lower MF and a higher RMS will be found after the fatigue protocol, especially in the hip flexors (M. rectus femoris) and the lower leg (M. gastrocnemius medialis, soleus, tibialis anterior and peroneus). Furthermore we hypothesize that no clinically relevant and statistically significant kinematic changes will occur in the sagittal plane for the ankle, knee and hip in this relatively well performing population.

Methods

This study was part of the larger study entitled “Functional electrical stimulation of the ankle dorsiflexors during walking in children with unilateral spastic cerebral palsy: a randomized crossover intervention study”. The Medical Ethical Committee of the MUMC approved the study (METC 172033/NL63250.068.17) and the trial was registered at ClinicalTrials.gov (NCT03440632). The full protocol was recently published [32].

Participants

Eighteen patients diagnosed with unilateral spastic cerebral palsy, aged between 4 and 18 years, GMFCS level I or II and unilateral drop foot of central origin, currently treated with an ankle-foot-orthosis (AFO) or adapted shoes, were included between September 2018 –September 2021. All participants and/or caregivers (if the participant was < 16 years) signed an informed consent form before participating in the study.

Procedure

For the main study all patients underwent two gait analyses with their conventional walking aid (mostly an AFO, otherwise adapted shoes), to support their drop foot during swing phase. In the current fatigue analysis, data from the first gait analysis with conventional walking aid was used, unless the second gait analysis had less missing data due to fallen sensors or poor signal to noise ratios. Gait analysis was performed at the ‘Computer Assisted Rehabilitation Environment’ (CAREN, MOTEK Medical, Amsterdam, Netherlands). The CAREN system consists of an dual-belt treadmill imbedded in a mobile platform with a force plate underneath each belt, surrounded by a motion-capture system based on reflective markers, twelve infrared Bonita 3D-cameras (100 Hz, Vicon Nexus, Oxford, UK) and three 2D video cameras. A 3D virtual reality environment is projected on an 180˚ cylindrical screen. The Human Body Model (HBM) II lower limb kinematic model with trunk markers (26 markers [33]) was used. Furthermore, a 16 channel surface electromyography system (Delsys Trigno, see appendix S1 in S1 Text for technical details) was used to measure muscle activity in both legs: 1. M. rectus femoris; 2. M. vastus lateralis; 3. M. semitendinosus; 4. M. biceps femoris; 5. M. gastrocnemius medialis; 6. M. soleus; 7. M. tibialis anterior and 8. M. peroneus longus. sEMG sensors are placed according to the SENIAM guidelines [34]. The position of the sensors was verified by visually checking the raw sEMG signal during individual muscle contractions. A resting state sEMG measurement was performed while the patient was in supine, relaxed position. All hardware was integrated in D-flow software (MOTEK Medical, Amsterdam, Netherlands).

For this fatigue analysis, data from two conditions was used: 1) Comfortable walking speed with walking aid, here after called ‘comfortable condition’ 2) Comfortable walking speed after the fatigue protocol, with walking aid, here after called ‘fatigued condition’. In every condition 250 steps (125 gait cycles) were measured. The comfortable walking speed with walking aid was determined by gradually increasing the speed of the treadmill with 0.01 m/s per second, starting at 0.5 m/s. The participant was asked to give a sign at the comfortable speed. This was repeated three times. The mean was considered the ‘comfortable walking speed’.

Fatigue protocol

The fatigue protocol was developed based on the Bruce protocol and the GMFCS treadmill protocols by Verschuren et al. [35, 36], to investigate the influence of walking-induced fatigue on the gait pattern. The patient was asked to give a score on the OMNI scale before the start of the fatigue protocol [37]. The OMNI scale ranges from 0 (totally not tired) to 10 (very, very tired). If the score was >2, a longer break for rest was implemented. During the fatigue protocol the speed and incline of the treadmill gradually increased and the patient was asked to walk as long as possible (Table 1 shows the details). If the patient indicated he could not walk further, despite motivational words, the protocol was stopped: the treadmill returned to a flat position. The final 125 gait cycles were immediately measured, at comfortable walking speed (in fatigued condition). At the moment the fatigue protocol was stopped, the patient was again asked to give a score on the children’s OMNI scale of perceived exertion for his degree of fatigue.

Table 1. Details of the fatigue protocol.

Stage Time (minutes) % walking speed of the comfortable speed Incline (°) Incline (%)
1 3 (0–2:59) 70% 2 3.5
2 3 (3–5:59) 85% 4 7.0
3 3 (6–8:59) 100% 6 10.5
4 3 (9–11:59) 115% 8 14.1
5 3 (12–14:59) 135% 10 17.6
6 3 (15–17:59) 140% 12 21.3
7 3 (18–20:59) 150% 12 21.3

Data analysis

The raw data (C3d files) from the gait analyses were loaded into MATLAB (MATLAB R2019b, The Mathworks Inc., Natick, MA, USA). The raw sEMG signals were band-pass filtered at 10 to 250 Hz using a 4th order Butterworth filter to remove low frequency motion artefacts and high frequency noise [38]. Gait cycles were identified as heelstrike to heelstrike from the same foot, based on the heel markers. Identified gait cycles were visually checked for consistency, where those typically shorter than 0.5 and longer than 1.5 seconds showed a deviation due to an incorrect additional or missing heelstrike. Gait cycles were then either manually corrected or removed to ensure that the included cycles were valid and consistent. Table S3 in the S1 Text shows the included number of gait cycles per patient per condition.

The MF is determined in Hertz as the median value of all valid gait cycles after individual Fourier transformations. Furthermore, sEMG was filtered with a root-mean-square window of 101ms, time normalized to 101 samples, and then averaged over all valid gait cycles. The RMS value in Volt is determined as the mean value of the active phase of a muscle based on the activation threshold. The activation threshold is set at the mean RMS value of the resting state sEMG signal plus two standard deviations, and hereafter called ‘noise’. To ensure good quality of the EMG data, only muscles that reach an average signal-to-noise ratio (SNR) of at least 5 during walking are included in the analysis.

Statistical analysis

Data distribution was checked using histograms and Q-Q plots. Patient characteristics and results of the fatigue protocol were described using mean and standard deviation. Changes in sEMG MF and RMS between the comfortable and fatigued condition were plotted in graphs with individual data and the mean with 95% confidence interval. Linear mixed effects models were applied for the MF and RMS separately, using the condition (comfortable or fatigued), the leg (affected or unaffected) and the muscle as fixed factors, an interaction term if applicable, a random intercept for subjects, and Bonferroni correction for multiple comparisons. These analyses were performed using IBM SPSS statistics version 24 (IBM Corp., Armonk, NY, USA).

Kinematics of the ankle, knee and hip in the sagittal plane were plotted using the group mean and standard deviations, based on individual means based on the valid cycles out of 125 gait cycles. Statistical (non)-parametric mapping (S(n)PM) was used to analyze possible differences between the comfortable and fatigued condition in kinematics over the whole gait cycle [39]. SPM is suitable for testing against critical values appropriate for smooth, spatially correlated time series, such as kinematics. This makes it possible to compare an entire waveform (0–100% of the gait cycle) instead of just specific timepoints. Technical details are provided elsewhere [40, 41]. SPM normality tests (spm1d.stats.normality.ttest_paired) were conducted for kinematics. Most of the kinematic curves were not normally distributed and therefore the statistical non-parametric mapping (SnPM) paired t-test (spm1d.stats.nonparam.ttest_paired) was used to compare the comfortable and fatigued condition. These analyses were done in MATLAB (MATLAB R2019b, The Mathworks Inc., Natick, MA, USA), using the SPM1D package (version 0.4, available at https://spm1d.org/index.html). For all SnPM tests the number of iterations was set at 1000 and statistically significant differences were not considered if they comprise ≤5% of the gait cycle, due to little clinical relevance [42]. A p-value of <0.05 was considered to be statistically significant for all analyses.

Results

Eighteen children with CP were included (mean age 9.8 years, SD 4.1 years, n = 6 female), of whom sixteen were classified as GMFCS level I and two as GMFCS level II. The mean comfortable walking speed was 1.11 m/s (SD 0.22 m/s). The mean fulfilled time of the fatigue protocol was 614.7 seconds (SD 184.9 seconds) and the mean OMNI fatigue score after the fatigue protocol was 7.7 (SD 2.1). The individual values and patient characteristics can be found in Table 2.

Table 2. Patient characteristics and results of the fatigue protocol.

Patient GMFCS level Sex Conventional walking aid Age in years Comfortable walking speed (m/s) Fulfilled time (min:sec) Stage fatigue protocol OMNI fatigue score (0–10)
1 I M D-AFO 5 1.00 06:45 3 7
2 I M D-AFO 10 0.97 08:50 3 6
3* I M D-AFO 6 1.08 12:17 5 10
4 I M Inlays 6 1.13 06:00 3 4
5 I M D-AFO 8 1.20 13:03 5 10
6 I M S-AFO 17 1.48 6:20 3 7
7* II F AFO 16 0.79 08:14 3 8
8* I M D-AFO 4 0.65 12:00 5 9
9 I F S-AFO 9 1.15 12:30 5 10
10* I F D-AFO 13 1.28 09:50 4 7
11 I M D-AFO 14 1.23 04:30 2 4
12 I M D-AFO 6 1.08 11:22 4 8
13* I M D-AFO 13 1.10 14:20 5 8
14 I F H-AFO 10 1.28 10:39 4 9
15 II M D-AFO 15 1.42 08:28 3 5
16 I F D-AFO 11 1.20 12:37 5 9
17* I M D-AFO 5 0.90 11:10 4 10
18 I F H-AFO 8 0.78 15:53 6 6

Abbreviations used: GMFCS, Gross Motor Function Classification System; M, male; F, female; AFO, ankle-foot-orthosis; D, dynamic; H, hinged; S, solid. * = measurement 2 was used due to more missing data in measurement 1 (due to sensors that fell off or poor SNR).

A typical individual example of the raw sEMG signal is presented in Fig 1. For the affected leg, sEMG data of the lower leg is mostly not available due to the walking aid: in the case of an AFO, there is no space for the sEMG sensors on the m. gastrocnemius, m. soleus and m. peroneus, and sometimes the tibialis anterior muscle. Also in two patients specific muscle signals had to be excluded, because sEMG sensors fell off during walking (5 sEMG sensors in total) e.g. due to sweating or the mechanical impact of foot-treadmill contact. Furthermore, in total 11 muscle signals of affected legs were excluded due to a low signal-to-noise ratio, and 33 muscle signals of unaffected legs, leaving sEMG data of 77 muscles of affected legs and 109 muscles of unaffected legs for analysis. Table 3 shows the numbers of available recordings per muscle.

Fig 1. Example of a raw sEMG signal of the gastrocnemius muscle.

Fig 1

Table 3. Estimated marginal means of the MF per muscle, based on the linear mixed-effects model.

Muscle N Condition Mean (Hz) Std error (Hz) df 95% confidence interval p-value
Lower bound Upper bound
RecF 54 Comfortable 60.6 4.1 147.1 52.5 68.6 0.05
Fatigued 50.8 42.7 58.9
VasL 52 Comfortable 58.0 4.1 151.7 49.8 66.2 0.58
Fatigued 55.2 47.0 63.4
SemT 60 Comfortable 59.5 4.0 135.6 51.7 67.4 0.79
Fatigued 60.8 53.0 68.6
BicF 62 Comfortable 69.9 3.9 126.5 62.3 77.6 0.13
Fatigued 62.9 55.3 70.6
GasM 34 Comfortable 92.7 9.8 345.4 73.5 111.9 0.91
Fatigued 91.2 72.0 110.4
Sole 32 Comfortable 85.4 9.8 345.5 66.2 104.6 0.95
Fatigued 84.6 65.4 103.8
TibA 56 Comfortable 84.5 4.1 146.8 76.4 92.6 <0.01
Fatigued 70.0 61.9 78.0
PerL 28 Comfortable 105.6 9.8 345.4 86.3 124.9 <0.01
Fatigued 57.4 38.1 76.7

Abbreviations used: MF: median frequency; RecF: rectus femoris; VasL: vastus lateralis; SemT: semitendinosus; BicF: biceps femoris; GasM: gastrocnemius; Sole: soleus; TibA: tibialis anterior; PerL: peroneus longus.

Changes in sEMG MF and RMS between the comfortable and fatigued condition per muscle per patient are shown in Fig 2, both for the affected leg and unaffected leg. The MF was significantly predicted by the condition (F(1, 329.10) = 10.62, p = 0.001), by the muscle (F(7, 333.39) = 11.64, p<0.001), by the muscle x condition (F(7, 329.10) = 2.30, p = 0.027) and by the leg x condition (F(1, 329.10) = 4.62, p = 0.032) interaction terms. No statistically significant main effect for leg (affected/unaffected) was found (F(1, 337.62) = 0.35, p = 0.58). Pairwise comparisons showed that the MF significantly decreased by 10.4±3.2 Hz in the fatigued condition. The estimated marginal means per muscle per condition are displayed in Table 3. Pairwise comparisons for the muscle x condition interaction showed that the decrease in MF in the fatigued condition was stronger for the TibA (mean decrease 14.8±5.2 Hz, (F(1, 298.34) = 8.15, p = 0.005)) and the PerL (mean decrease 48.3±13.8 Hz, (F(1, 298.34) = 12.31, p = 0.001)) than for other muscles. Pairwise comparisons for the leg x condition interaction showed that the decrease in MF in the fatigued condition was stronger for the affected leg (mean decrease 16.8±6.1 Hz, (F(1, 298.34) = 7.61, p = 0.006) than for the unaffected leg.

Fig 2.

Fig 2

Changes in sEMG median frequency (MF, panel A) and root mean square (RMS, panel B) between the comfortable and fatigued condition; for the affected leg (graphs on the left) and unaffected leg (graphs on the right). The change is calculated as the difference between the value after the fatigue protocol minus the value before the fatigue protocol per muscle per patient and displayed on the x-axis. The y-axis shows the different muscles. Abbreviations used: RecF: rectus femoris; VasL: vastus lateralis; SemT: semitendinosus; BicF: biceps femoris; GasM: gastrocnemius; Sole: soleus; TibA: tibialis anterior; PerL: peroneus longus.

The linear mixed-effects model for RMS didn’t show any statistically significant effect of condition (F(1, 325.66) = 0.28, p = 0.60), muscle (F(7, 335.79) = 0.08, p = 1.0) or the leg (F(1, 344.85) = 0.15, p = 0.70) (Table 4).

Table 4. Estimated marginal means of the RMS per muscle, based on the linear mixed-effects model.

Muscle N Condition Mean (V) Std error (V) df 95% confidence interval
Lower bound Upper bound
RecF 54 Comfortable 0.022 0.010 294.185 0.002 0.041
Fatigued 0.045 0.026 0.064
VasL 52 Comfortable 0.025 0.010 299.360 0.005 0.044
Fatigued 0.035 0.015 0.054
SemT 60 Comfortable 0.032 0.009 290.844 0.013 0.050
Fatigued 0.027 0.008 0.046
BicF 62 Comfortable 0.036 0.009 284.211 0.018 0.054
Fatigued 0.026 288.969 0.008 0.045
GasM 34 Comfortable 0.033 0.026 344.262 -0.018 0.083
Fatigued 0.039 -0.012 0.089
Sole 32 Comfortable 0.030 0.026 343.796 -0.021 0.081
Fatigued 0.027 -0.024 0.078
TibA 56 Comfortable 0.030 0.010 297.466 0.011 0.049
Fatigued 0.025 0.006 0.045
PerL 28 Comfortable 0.025 0.026 344.353 -0.026 0.076
Fatigued 0.044 -0.007 0.095

Abbreviations used: RMS: root mean square; RecF: rectus femoris; VasL: vastus lateralis; SemT: semitendinosus; BicF: biceps femoris; GasM: gastrocnemius; Sole: soleus; TibA: tibialis anterior; PerL: peroneus longus.

Fig 3 shows the mean sagittal plane kinematics of the ankle, knee and hip for the comfortable condition and the fatigued condition, both for the affected and unaffected leg. SnPM paired t-tests showed no statistically significant differences in kinematics between the comfortable and fatigued condition, except for the unaffected ankle (±1.3° more dorsiflexion during stance phase (40.0–47.5% of the gait cycle) in the fatigued condition) (See the appendix S2 in S1 Text for SnPM figures.

Fig 3.

Fig 3

Mean sagittal plane kinematics of the ankle, knee and hip of the affected leg (graphs on the left) and unaffected leg (graphs on the right), for the comfortable (black line) and fatigued condition (grey line). N = 18.

Discussion

Based on the MF and the OMNI fatigue score, the current fatigue protocol seems promising in inducing fatigue in a population with CP and drop foot, while no changes RMS and in sagittal kinematics of hip, knee and ankle occurred.

The results rejected our first hypothesis because the RMS did not show a statistically significant increase in the fatigued condition, although the MF decreased significantly in the fatigued condition compared to the comfortable condition as expected. The decrease in MF in fatigued condition was stronger for the affected leg and for the m. tibialis anterior and m. peroneus longus. The rectus femoris muscle did not show statistically significant signs of fatigue in pairwise comparisons, rejecting our hypothesis that signs of fatigue would occur in the hip flexors after walking uphill.

Regarding kinematics, our hypothesis that no significant changes in sagittal plane kinematics of ankle, knee and hip would occur, was confirmed. The 1.3° increase in dorsiflexion in stance phase (40.0–47.5% of the gait cycle) in fatigued condition for the unaffected ankle is considered clinically irrelevant as it is smaller than the minimally detectable change [43, 44]. Thus, the fatigue protocol did not result in altered kinematics: the patients were still able to maintain their gait pattern (at the same walking speed). This result could be interpreted as an indication that the current study population is physically quite well-performing and that, despite the challenging fatigue protocol and sEMG signs of fatigue, the muscle fatigue did not limit their walking performance. It should be noted that the patients wore their walking aid (mostly an AFO) and this might have helped them to maintain a stable gait pattern. Despite the AFO, it was not impossible for kinematics to change, because most patients wore a dynamic AFO, which does allow some movement in the ankle joint. Besides, compensatory mechanisms such as changing step length or using circumduction could have been applied (leading to kinematic changes).

A decrease in MF and an increase in RMS are generally described to occur together in muscle fatigue. Cifrek et al. report that in the case of a decrease in MF, a decrease in RMS points to a decrease in muscle force, while an increase in RMS points to muscle fatigue [26]. However, fatigue and decrease in force are often related. In our study, the decrease in MF was apparently not accompanied by substantial decline in force, as the RMS values did not change due to the fatigue protocol, while the kinematics stayed the same. Moreover, factors such as perspiration can influence sEMG signals: it is reported that sweat decreases the RMS, but has less influence on MF [45]. Some patients in our study were noticeably sweating during the fatigue protocol and this may have affected the RMS. Unfortunately we cannot correct for this. It is likely that both central and peripheral fatigue occur in children with CP. However, their contribution cannot be assessed based on the current sEMG measurements.

Our study has several limitations. First of all, due to the fact that the 3D gait analyses were performed with a walking aid, limited data of the muscles of the affected lower leg was available. It should be noted that conclusions regarding the ankle muscles were based on available data mostly from the unaffected leg. Even while data from the ankle muscles of the affected leg were mostly missing, the linear mixed effects model showed that the decrease in MF was stronger in the affected leg and (separately) in the TibA and PerL muscles. Based on previous findings [16], we expected that especially these muscles would show sEMG signs of fatigue in this population. Hence, the effects of this study may be underestimated and could have been stronger if sEMG measurements of these muscles in the affected leg would have been included. Also, it would have been valuable if more muscles could have been included in sEMG measurement, especially the gluteus muscles, as hip extension contributes to positive power during uphill walking.

Secondly, we compared two conditions: walking in comfortable and fatigued condition at comfortable speed, without taking change over time into account. We did not assess whether fatigue was possibly already building up during the comfortable condition or declining in the fatigued condition (by comparing individual gait cycles). However, it was not the aim of this article to investigate how fast sEMG signs of fatigue occur or recover.

In the third place, it should be noted that patients walked uphill in order to induce fatigue. Walking uphill could induce fatigue in other muscles than walking on level ground. As stated before, the contribution to positive power increases for the hip and decreases for the ankle during uphill walking. Therefore, it could be expected that the rectus femoris (hip flexor) would be more fatigued in our study. This was however not the case. Apparently, even after uphill walking, muscle fatigue is still more pronounced in distal muscles in children with CP [46].

Finally, for the feasibility of the measurements, we didn’t measure other objective parameters of the amount of physical strain, such as the heartrate or oxygen consumption to assess fatigue. Despite the lack of these objective parameters, we think that the fatigue protocol can be considered a ‘maximal exercise’, as are the Bruce and GMFCS treadmill protocols [35, 36]: the patient is forced to quit the task because of fatigue and exhausting [47]. This is especially the case when patients stop the protocol when they are really fatigued. The mean OMNI fatigue score of 7.7 reflects feeling really fatigued, however three patients only gave score 4 or 5 for fatigue. It seemed that one of these patients had some difficulties using the OMNI fatigue scale and the other two patients didn’t seem to want to admit that they were really tired.

In conclusion, signs of fatigue are found after the fatigue protocol, namely a decrease in sEMG MF, especially in the affected leg and in the tibialis anterior and peroneus longus muscle, and a high OMNI fatigue score. Hence, the developed treadmill based fatigue protocol with increasing incline and speed, is effective in inducing fatigue in a population of children with CP (GMFCS level I-II). We think this fatigue protocol is suitable for future research, to expand the knowledge on muscle fatigue during walking in children with CP and its implications for gait and therapy. As expected, no kinematic changes were found in the fatigued condition for the ankle, knee and hip in the sagittal plane.

The current results are relevant for future research. First of all, after showing that the fatigue protocol is effective in inducing muscle fatigue, especially in the lower leg, this study offers a tailored protocol for children with CP to induce muscle fatigue. Second, this fatigue protocol makes it possible to evaluate changes in muscle fatigue after treatment or training programs. It could be investigated whether muscle strength and muscle spasticity, which are often treatment targets, are factors directly influencing muscle fatigue. Although we didn’t find relevant kinematic changes, this study highlights the importance of taking kinematics into account, as they are directly influenced by muscle activity. Future research could focus on changes in kinematics during fatigue, with and without walking aid.

Supporting information

S1 Text. This file contains all the supporting tables and figures.

(DOCX)

S1 Data

(XLSX)

S1 File

(ZIP)

S2 File

(ZIP)

S3 File

(ZIP)

Acknowledgments

The authors are grateful to the participating children and their parents for their time and effort. The authors also thank Paul J.B. Willems for the technical implementation of the fatigue protocol at the CAREN. Furthermore, the authors want to thank M. Coenen, E. Claassen, R. Hovenier, D. Heijnen and E. Stoop for their help with the measurements.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

There are no competing interests to declare. This study is part of a larger study entitled “Functional electrical stimulation of the ankle dorsiflexors during walking in children with unilateral spastic cerebral palsy: a randomized crossover intervention study” (ClinicalTrials.gov number NCT03440632) which is funded by HandicapNL (formerly Revalidatiefonds, project number R201605614, RJV), in collaboration with the Cornelia Stichting. No sponsor/funder played any role in study design, data collection and analysis, decision to publish and preparation of the manuscript.

References

  • 1.Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109(suppl 109):8–14. [PubMed] [Google Scholar]
  • 2.Krigger KW. Cerebral palsy: an overview. Am Fam Physician. 2006;73(1):91–100. [PubMed] [Google Scholar]
  • 3.Reddihough DS, Collins KJ. The epidemiology and causes of cerebral palsy. Australian Journal of physiotherapy. 2003;49(1):7–12. doi: 10.1016/s0004-9514(14)60183-5 [DOI] [PubMed] [Google Scholar]
  • 4.Oskoui M, Coutinho F, Dykeman J, Jette N, Pringsheim T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Developmental medicine and child neurology. 2013;55(6):509–19. Epub 2013/01/26. doi: 10.1111/dmcn.12080 . [DOI] [PubMed] [Google Scholar]
  • 5.Sellier E, Platt MJ, Andersen GL, Krägeloh-Mann I, De La Cruz J, Cans C. Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003. Developmental medicine and child neurology. 2016;58(1):85–92. Epub 2015/09/04. doi: 10.1111/dmcn.12865 . [DOI] [PubMed] [Google Scholar]
  • 6.Himmelmann K, Uvebrant P. The panorama of cerebral palsy in Sweden part XII shows that patterns changed in the birth years 2007–2010. Acta paediatrica. 2018;107(3):462–8. doi: 10.1111/apa.14147 [DOI] [PubMed] [Google Scholar]
  • 7.Gage JR, Schwartz MH, Koop SE, Novacheck TF. Chapter 2.4 Consequences Of Brain Injury On Musculoskeletal Development. The Identification and Treatment of Gait Problems in Cerebral Palsy. Clinics in Developmental Medicine Nos 180–181: Mac Keith Press; 2009. p. 107–29. [Google Scholar]
  • 8.Rodda J, Graham HK. Classification of gait patterns in spastic hemiplegia and spastic diplegia: a basis for a management algorithm. European journal of neurology: the official journal of the European Federation of Neurological Societies. 2001;8 Suppl 5:98–108. Epub 2002/02/20. doi: 10.1046/j.1468-1331.2001.00042.x . [DOI] [PubMed] [Google Scholar]
  • 9.Rose J, Gamble JG, Burgos A, Medeiros J, Haskell WL. Energy expenditure index of walking for normal children and for children with cerebral palsy. Developmental Medicine & Child Neurology. 1990;32(4):333–40. doi: 10.1111/j.1469-8749.1990.tb16945.x [DOI] [PubMed] [Google Scholar]
  • 10.Ratel S, Doré E, Duché P. Measuring levels of muscle fatigue in spastic cerebral palsy. Developmental Medicine & Child Neurology. 2019;61(2):118–9. doi: 10.1111/dmcn.14046 [DOI] [PubMed] [Google Scholar]
  • 11.Dallmeijer AJ, Brehm M-A. Physical strain of comfortable walking in children with mild cerebral palsy. Disability and rehabilitation. 2011;33(15–16):1351–7. doi: 10.3109/09638288.2010.531374 [DOI] [PubMed] [Google Scholar]
  • 12.Johnston TE, Moore SE, Quinn LT, Smith BT. Energy cost of walking in children with cerebral palsy: Relation to the Gross Motor Function Classification System. Developmental medicine and child neurology. 2004;47(1):34–8. doi: 10.1017/S0012162204000064 [DOI] [PubMed] [Google Scholar]
  • 13.Eken MM, Houdijk H, Doorenbosch CA, Kiezebrink FE, van Bennekom CA, Harlaar J, et al. Relations between muscle endurance and subjectively reported fatigue, walking capacity, and participation in mildly affected adolescents with cerebral palsy. Developmental Medicine & Child Neurology. 2016;58(8):814–21. doi: 10.1111/dmcn.13083 [DOI] [PubMed] [Google Scholar]
  • 14.Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology. 2013;80(4):409–16. doi: 10.1212/WNL.0b013e31827f07be [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Van Geel F, Moumdjian L, Lamers I, Bielen H, Feys P. Measuring walking-related performance fatigability in clinical practice: a systematic review. Eur J Phys Rehabil Med. 2020;56(1):88–103. Epub 2019/11/20. doi: 10.23736/S1973-9087.19.05878-7 . [DOI] [PubMed] [Google Scholar]
  • 16.Eken MM, Brændvik SM, Bardal EM, Houdijk H, Dallmeijer AJ, Roeleveld K. Lower limb muscle fatigue during walking in children with cerebral palsy. Developmental Medicine & Child Neurology. 2019;61(2):212–8. doi: 10.1111/dmcn.14002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chaudhuri A, Behan PO. Fatigue in neurological disorders. The Lancet. 2004;363(9413):978–88. doi: 10.1016/S0140-6736(04)15794-2 [DOI] [PubMed] [Google Scholar]
  • 18.Eken MM, Dallmeijer AJ, Doorenbosch CA, Dekkers H, Becher JG, Houdijk H. Assessment of muscle endurance of the knee extensor muscles in adolescents with spastic cerebral palsy using a submaximal repetitions-to-fatigue protocol. Archives of physical medicine and rehabilitation. 2014;95(10):1888–94. doi: 10.1016/j.apmr.2014.05.010 [DOI] [PubMed] [Google Scholar]
  • 19.Eken MM, Dallmeijer AJ, Houdijk H, Doorenbosch C. Muscle fatigue during repetitive voluntary contractions: A comparison between children with cerebral palsy, typically developing children and young healthy adults. Gait & posture. 2013;38(4):962–7. doi: 10.1016/j.gaitpost.2013.05.004 [DOI] [PubMed] [Google Scholar]
  • 20.Neyroud D, Armand S, De Coulon G, Sarah RDDS, Maffiuletti NA, Kayser B, et al. Plantar flexor muscle weakness and fatigue in spastic cerebral palsy patients. Res Dev Disabil. 2017;61:66–76. Epub 2017/01/09. doi: 10.1016/j.ridd.2016.12.015 . [DOI] [PubMed] [Google Scholar]
  • 21.Stackhouse SK, Binder‐Macleod SA, Lee SC. Voluntary muscle activation, contractile properties, and fatigability in children with and without cerebral palsy. Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine. 2005;31(5):594–601. doi: 10.1002/mus.20302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Avin KG, Naughton MR, Ford BW, Moore HE, Monitto-Webber MN, Stark AM, et al. Sex differences in fatigue resistance are muscle group dependent. Med Sci Sports Exerc. 2010;42(10):1943–50. Epub 2010/03/03. doi: 10.1249/MSS.0b013e3181d8f8fa ; PubMed Central PMCID: PMC2917609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Marbini A, Ferrari A, Cioni G, Bellanova M, Fusco C, Gemignani F. Immunohistochemical study of muscle biopsy in children with cerebral palsy. Brain and Development. 2002;24(2):63–6. doi: 10.1016/s0387-7604(01)00394-1 [DOI] [PubMed] [Google Scholar]
  • 24.Rose J, McGill KC. Neuromuscular activation and motor‐unit firing characteristics in cerebral palsy. Developmental Medicine & Child Neurology. 2005;47(5):329–36. doi: 10.1017/s0012162205000629 [DOI] [PubMed] [Google Scholar]
  • 25.González-Izal M, Malanda A, Gorostiaga E, Izquierdo M. Electromyographic models to assess muscle fatigue. Journal of Electromyography and Kinesiology. 2012;22(4):501–12. doi: 10.1016/j.jelekin.2012.02.019 [DOI] [PubMed] [Google Scholar]
  • 26.Cifrek M, Medved V, Tonković S, Ostojić S. Surface EMG based muscle fatigue evaluation in biomechanics. Clinical Biomechanics. 2009;24(4):327–40. doi: 10.1016/j.clinbiomech.2009.01.010 [DOI] [PubMed] [Google Scholar]
  • 27.Bigland-Ritchie B, Woods JJ. Changes in muscle contractile properties and neural control during human muscular fatigue. Muscle & nerve. 1984;7(9):691–9. Epub 1984/11/01. doi: 10.1002/mus.880070902 . [DOI] [PubMed] [Google Scholar]
  • 28.Parent A, Maso FD, Pouliot-Laforte A, Cherni Y, Marois P, Ballaz L. Short walking exercise leads to gait changes and muscle fatigue in children with cerebral palsy who walk with jump gait. American journal of physical medicine & rehabilitation / Association of Academic Physiatrists. 2021. Epub 2021/02/16. doi: 10.1097/PHM.0000000000001713 . [DOI] [PubMed] [Google Scholar]
  • 29.Parent A, Pouliot-Laforte A, Dal Maso F, Cherni Y, Marois P, Ballaz L. Muscle fatigue during a short walking exercise in children with cerebral palsy who walk in a crouch gait. Gait & posture. 2019;72:22–7. Epub 2019/05/28. doi: 10.1016/j.gaitpost.2019.05.021 . [DOI] [PubMed] [Google Scholar]
  • 30.Parent A, Raison M, Pouliot-Laforte A, Marois P, Maltais DB, Ballaz L. Impact of a short walking exercise on gait kinematics in children with cerebral palsy who walk in a crouch gait. Clinical biomechanics (Bristol, Avon). 2016;34:18–21. Epub 2016/04/04. doi: 10.1016/j.clinbiomech.2016.03.003 . [DOI] [PubMed] [Google Scholar]
  • 31.Nuckols RW, Takahashi KZ, Farris DJ, Mizrachi S, Riemer R, Sawicki GS. Mechanics of walking and running up and downhill: A joint-level perspective to guide design of lower-limb exoskeletons. PLoS One. 2020;15(8):e0231996. Epub 2020/08/29. doi: 10.1371/journal.pone.0231996 ; PubMed Central PMCID: PMC7454943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Moll I, Marcellis RGJ, Coenen MLP, Fleuren SM, Willems PJB, Speth LAWM, et al. A randomized crossover study of functional electrical stimulation during walking in spastic cerebral palsy: the FES on participation (FESPa) trial. BMC pediatrics. 2022;22(1):37. doi: 10.1186/s12887-021-03037-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.van den Bogert AJ, Geijtenbeek T, Even-Zohar O, Steenbrink F, Hardin EC. A real-time system for biomechanical analysis of human movement and muscle function. Medical & biological engineering & computing. 2013;51(10):1069–77. doi: 10.1007/s11517-013-1076-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hermens HJ, Freriks B, Merletti R, Stegeman D, Blok J, Rau G, et al. European recommendations for surface electromyography. Roessingh research and development. 1999;8(2):13–54. [Google Scholar]
  • 35.Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. American heart journal. 1973;85(4):546–62. doi: 10.1016/0002-8703(73)90502-4 [DOI] [PubMed] [Google Scholar]
  • 36.Verschuren O, Takken T, Ketelaar M, Gorter JW, Helders PJ. Reliability and validity of data for 2 newly developed shuttle run tests in children with cerebral palsy. Physical therapy. 2006;86(8):1107–17. [PubMed] [Google Scholar]
  • 37.Robertson RJ, Goss FL, Boer NF, Peoples JA, Foreman AJ, Dabayebeh IM, et al. Children’s OMNI Scale of Perceived Exertion: mixed gender and race validation. Medicine & Science in Sports & Exercise. 2000;32(2):452. 00005768-200002000-00029. doi: 10.1097/00005768-200002000-00029 [DOI] [PubMed] [Google Scholar]
  • 38.Konrad P. The abc of emg. A practical introduction to kinesiological electromyography. 2005;1:30–5. [Google Scholar]
  • 39.Pataky TC, Robinson MA, Vanrenterghem J. Region-of-interest analyses of one-dimensional biomechanical trajectories: bridging 0D and 1D theory, augmenting statistical power. PeerJ. 2016;4:e2652. doi: 10.7717/peerj.2652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Pataky TC. Generalized n-dimensional biomechanical field analysis using statistical parametric mapping. Journal of Biomechanics. 2010;43(10):1976–82. doi: 10.1016/j.jbiomech.2010.03.008 [DOI] [PubMed] [Google Scholar]
  • 41.Pataky TC, Vanrenterghem J, Robinson MA. Zero- vs. one-dimensional, parametric vs. non-parametric, and confidence interval vs. hypothesis testing procedures in one-dimensional biomechanical trajectory analysis. Journal of Biomechanics. 2015;48(7):1277–85. doi: 10.1016/j.jbiomech.2015.02.051 [DOI] [PubMed] [Google Scholar]
  • 42.Simon-Martinez C, Mailleux L, Jaspers E, Ortibus E, Desloovere K, Klingels K, et al. Effects of combining constraint-induced movement therapy and action-observation training on upper limb kinematics in children with unilateral cerebral palsy: a randomized controlled trial. Scientific reports. 2020;10(1):10421. Epub 2020/06/28. doi: 10.1038/s41598-020-67427-2 ; PubMed Central PMCID: PMC7320002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.McGinley JL, Baker R, Wolfe R, Morris ME. The reliability of three-dimensional kinematic gait measurements: a systematic review. Gait & posture. 2009;29(3):360–9. Epub 2008/11/18. doi: 10.1016/j.gaitpost.2008.09.003 . [DOI] [PubMed] [Google Scholar]
  • 44.Klejman S, Andrysek J, Dupuis A, Wright V. Test-retest reliability of discrete gait parameters in children with cerebral palsy. Archives of physical medicine and rehabilitation. 2010;91(5):781–7. doi: 10.1016/j.apmr.2010.01.016 [DOI] [PubMed] [Google Scholar]
  • 45.Abdoli-Eramaki M, Damecour C, Christenson J, Stevenson J. The effect of perspiration on the sEMG amplitude and power spectrum. Journal of Electromyography and Kinesiology. 2012;22(6):908–13. doi: 10.1016/j.jelekin.2012.04.009 [DOI] [PubMed] [Google Scholar]
  • 46.Wiley ME, Damiano DL. Lower‐extremity strength profiles in spastic cerebral palsy. Developmental Medicine & Child Neurology. 1998;40(2):100–7. doi: 10.1111/j.1469-8749.1998.tb15369.x [DOI] [PubMed] [Google Scholar]
  • 47.Taylor C. Some properties of maximal and submaximal exercise with reference to physiological variation and the measurement of exercise tolerance. American Journal of Physiology-Legacy Content. 1944;142(2):200–12. [Google Scholar]

Decision Letter 0

Xin Ye

9 Sep 2022

PONE-D-22-21864Lower limb muscle fatigue after uphill walking in children with unilateral spastic cerebral palsyPLOS ONE

Dear Dr. Moll,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Xin Ye, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. Please remove your figures from within your manuscript file, leaving only the individual TIFF/EPS image files, uploaded separately.  These will be automatically included in the reviewers’ PDF.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the opportunity to review such a thoughtful experiment. The authors use well established protocols and methods to investigate a useful research question- the relationship among sEMG, perceived exertion, and gait kinematics. The authors encounter usual challenges with use of AFOs with gait analysis and application of sEMG and are able to still produce useful data.

The authors are encouraged to re examine the introduction, there are many statements about the muscles and fatigability of individuals with CP that are not referenced. There are also issues with changing tenses within the body of text of the methods. There may also be some literature that could be cited on energy expenditure and GMFCS I unilateral to provide context about the participants chosen for the fatigue protocol.

The authors miss an opportunity to provide a concise statement about their findings in the initial paragraph of the discussion. I like the way it is summarized in the abstract it is much clearer and powerful than the way it is described in the discussion.

Given all the differences in muscle morphology and physiology and fiber types how might you explain the findings? Please expand a little more what you think these findings tell us about central vs peripheral fatigue? Because of the OMNI scores do you think central fatigue is a bigger factor than peripheral?

Reviewer #2: This study presents results of original research that do not appear to have been published elsewhere. This is an interesting fatigue protocol for children with mild cerebral palsy. While the experiments appear to have been performed with high technical standards, additional detail is needed and some concerns for missing data need to be addressed before the conclusions can be justified.

Of greatest concern is the fact that EMG data for the ankle was completely missing for 3 out of 4 ankle muscles for the affected leg in all participants, yet conclusions were made regarding significant changes in frequency for two of the ankle muscles. It must be assumed that these decisions were determined with less than half the data available.

While there were 18 participants, all but one child wore an AFO during the assessment so at the most only one child would have data from both ankles. Therefore, no comparisons can be made between affected and unaffected ankles and any conclusions about the ankle responses is incomplete and represents only the unaffected leg.

The actual amount of data used for each participant is not clear. Data were collected for 250 steps before and after fatigue, however, only “valid steps” were included. More information is needed regarding how many valid steps were found for each participant under each condition. Gait cycles that were shorter than 0.5 or longer than 1.5 seconds were removed. Additional clarification and justification for this decision could be helpful to the reader.

The conclusions are presented in an appropriate fashion however, there are many unanswered questions that need to be resolved and further justification is needed to support the conclusions.

It is unclear why the authors expected to see fatigue related changes in kinematics when AFOs were worn for data collection. The AFO will dictate kinematics for the affected leg to a great extent and could also have interfered with muscle activity thus reducing potential for fatigue. This decision requires further explanation and justification.

Also, it is unclear why hip extensor or abductor emg data were not included in this data set since they should be activated and fatigued by uphill walking.

The article is presented in an intelligible fashion and is written in standard English, however, the authors should use people first language. Throughout the text they refer to children with cerebral palsy as ‘CP patients’.

Ethical standards appear to have been met with informed consent and IRB approval.

There are some problems with data availability. The supplementary data provided does not represent full disclosure of the data. Only a single, normalized mean was provided as kinematic data for each participant for each condition. Presumably hundreds of steps were included in creating that mean, however no individual step data is provided and it is unknown how many steps were considered valid for each participant.

EMG data were not accessible by this reviewer in the .sav file extension format. This was unreadable in wordpad or textedit. Is it possible to make the supplementary data more easily accessible to a wide variety of readers?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mary E Gannotti

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 6;17(12):e0278657. doi: 10.1371/journal.pone.0278657.r002

Author response to Decision Letter 0


17 Oct 2022

Reviewer #1: Thank you for the opportunity to review such a thoughtful experiment. The authors use well established protocols and methods to investigate an useful research question- the relationship among sEMG, perceived exertion, and gait kinematics. The authors encounter usual challenges with use of AFOs with gait analysis and application of sEMG and are able to still produce useful data.

The authors are encouraged to re-examine the introduction, there are many statements about the muscles and fatigability of individuals with CP that are not referenced.

Thank you for your comments. Based on this remark, some references were added in the Background section (in red in the manuscript file):

GAGE, J. R., SCHWARTZ, M. H., KOOP, S. E. & NOVACHECK, T. F. 2009. Chapter 2.4 Consequences Of Brain Injury On Musculoskeletal Development. The Identification and Treatment of Gait Problems in Cerebral Palsy. Mac Keith Press.

EKEN, M. M., BRÆNDVIK, S. M., BARDAL, E. M., HOUDIJK, H., DALLMEIJER, A. J. & ROELEVELD, K. 2019. Lower limb muscle fatigue during walking in children with cerebral palsy.

EKEN, M. M., HOUDIJK, H., DOORENBOSCH, C. A., KIEZEBRINK, F. E., VAN BENNEKOM, C. A., HARLAAR, J. & DALLMEIJER, A. J. 2016. Relations between muscle endurance and subjectively reported fatigue, walking capacity, and participation in mildly affected adolescents with cerebral palsy. Developmental Medicine & Child Neurology, 58, 814-821.

There are also issues with changing tenses within the body of text of the methods.

The tense has been changed to past tense for the whole section.

There may also be some literature that could be cited on energy expenditure and GMFCS I unilateral to provide context about the participants chosen for the fatigue protocol.

It is true that some more specific attention could be put on GMFCS level I, although the used references give information on GMFCS level I. It was now emphasized that the energy expenditure is also higher in GMFCS I compared to typically developing children: ‘This makes walking less energy efficient in CP patients (Rose et al., 1990, Ratel et al., 2019), even in Gross Motor Function Classification System (GMFCS) level I (Dallmeijer and Brehm, 2011, Johnston et al., 2004)’

The authors miss an opportunity to provide a concise statement about their findings in the initial paragraph of the discussion. I like the way it is summarized in the abstract it is much clearer and powerful than the way it is described in the discussion.

Thank you for the suggestion. The first sentence of the discussion has been changed: Based on the MF and the OMNI fatigue score, the current fatigue protocol seems promising in inducing fatigue in a CP population with drop foot, while no changes in RMS and sagittal kinematics of hip, knee and ankle occurred.

Given all the differences in muscle morphology and physiology and fiber types how might you explain the findings? Please expand a little more what you think these findings tell us about central vs peripheral fatigue? Because of the OMNI scores do you think central fatigue is a bigger factor than peripheral?

It could be stated that a decrease in MF reflects peripheral fatigue (related to accumulation of metabolic products in the muscle) and that an increase in RMS reflects central fatigue (increase in neural drive). The fact that the kinematics stayed stable in our study, could suggest that the force generating capacity (peripheral fatigue) remained sufficient, although the MF decreased. The OMNI score reflects subjective fatigue, which can both be central and peripheral. However, as stated, the contribution of central and peripheral fatigue cannot be assessed based on our measurements, because factors such as perspiration, which can decrease the RMS, should also be taken in to account. We think central and peripheral fatigue should be considered as occurring together.

Reviewer #2: This study presents results of original research that do not appear to have been published elsewhere. This is an interesting fatigue protocol for children with mild cerebral palsy. While the experiments appear to have been performed with high technical standards, additional detail is needed and some concerns for missing data need to be addressed before the conclusions can be justified. Of greatest concern is the fact that EMG data for the ankle was completely missing for 3 out of 4 ankle muscles for the affected leg in all participants, yet conclusions were made regarding significant changes in frequency for two of the ankle muscles. It must be assumed that these decisions were determined with less than half the data available.

It is correct that most data on ankle muscles of the affected leg was missing due to AFOs, and that results on ankle muscles were therefore based on less data. This was also stated in the discussion (Limitations section): ‘Our study has several limitations. First of all, due to the fact that the 3D gait analyses were performed with a walking aid, limited data of the muscles of the affected lower leg was available. Based on previous findings (Eken et al., 2019), we expected that especially these muscles would show sEMG signs of fatigue in this population. Hence, the effects of this study may be underestimated and could have been stronger if sEMG measurements of these muscles would have been included.’

To be more clear about the missing data, the text has been adjusted:

‘Our study has several limitations. First of all, due to the fact that the 3D gait analyses were performed with a walking aid, limited data of the muscles of the affected lower leg was available. It should be noted that conclusions regarding the ankle muscles were based on available data mostly from the unaffected leg. Even while data from the ankle muscles of the affected leg were mostly missing, the linear mixed effects model showed that the decrease in MF was stronger in the affected leg and (separately) in the TibA and PerL muscles. Based on previous findings (Eken et al., 2019), we expected that especially these muscles would show sEMG signs of fatigue in this population. Hence, the effects of this study may be underestimated and could have been stronger if sEMG measurements of these muscles in the affected leg would have been included.’

While there were 18 participants, all but one child wore an AFO during the assessment so at the most only one child would have data from both ankles. Therefore, no comparisons can be made between affected and unaffected ankles and any conclusions about the ankle responses is incomplete and represents only the unaffected leg.

This is correct again, although data on the tibialis anterior muscle (one of the four ankle muscles) was available for the affected leg in most cases. We refer to the added text in the answer above. We think a comparison between the affected leg and unaffected leg can be made, because for five muscles data from both leg were more or less completely available. Also, the linear mixed effects model does not compare the ankle muscles in the affected and unaffected leg, but compares the legs in total.

The actual amount of data used for each participant is not clear. Data were collected for 250 steps before and after fatigue, however, only “valid steps” were included. More information is needed regarding how many valid steps were found for each participant under each condition.

Thank you for your question. A table with the number of included valid gait cycles per patient per condition was added as Appendix S3.

S3: Number of valid gait cycles per patient per condition

Patient number F-Patient number** Affected side Condition Number of valid gait cycles

1 2 Right Comfortable 127

1 2 Right Fatigued 62

2 3 Left Comfortable 127

2 3 Left Fatigued 149

3* 4* Left Comfortable 129

3* 4* Left Fatigued 128

4 5 Left Comfortable 127

4 5 Left Fatigued 128

5 6 Left Comfortable 129

5 6 Left Fatigued 130

6 8 Right Comfortable 128

6 8 Right Fatigued 121

7* 9* Right Comfortable 127

7* 9* Right Fatigued 121

8* 10* Left Comfortable 136

8* 10* Left Fatigued 131

9 12 Right Comfortable 138

9 12 Right Fatigued 129

10 13 Left Comfortable 133

10 13 Left Fatigued 131

11 14 Right Comfortable 146

11 14 Right Fatigued 159

12 18 Left Comfortable 130

12 18 Left Fatigued 128

13* 19* Left Comfortable 128

13* 19* Left Fatigued 144

14 20 Right Comfortable 128

14 20 Right Fatigued 128

15 21 Right Comfortable 133

15 21 Right Fatigued 130

16 23 Right Comfortable 138

16 23 Right Fatigued 129

17* 24* Left Comfortable 129

17* 24* Left Fatigued 129

18 25 Left Comfortable 136

18 25 Left Fatigued 140

* = measurement 2 was used due to more missing data in measurement 1 (due to sensors that fell off or poor SNR). ** = the original patient number, also used in the individual kinematic Excel files (Supplementary data).

Gait cycles that were shorter than 0.5 or longer than 1.5 seconds were removed. Additional clarification and justification for this decision could be helpful to the reader.

Thank you for your question. The text in the manuscript has been elaborated:

Original: ‘Gait cycles are identified as heelstrike to heelstrike from the same foot, based on the heel markers. Identified gait cycles shorter than 0.5 or longer than 1.5 seconds were removed to ensure that the included steps were valid and consistent.’

New version: ‘Gait cycles were identified as heelstrike to heelstrike from the same foot, based on the heel markers. Identified gait cycles were visually checked for consistency, where those typically shorter than 0.5 and longer than 1.5 seconds showed a deviation due to an incorrect additional or missing heelstrike. Gait cycles were then either manually corrected or removed to ensure that the included cycles were valid and consistent.’

The conclusions are presented in an appropriate fashion however, there are many unanswered questions that need to be resolved and further justification is needed to support the conclusions.

It is unclear why the authors expected to see fatigue related changes in kinematics when AFOs were worn for data collection. The AFO will dictate kinematics for the affected leg to a great extent and could also have interfered with muscle activity thus reducing potential for fatigue. This decision requires further explanation and justification.

First of all, the hypothesis was that no significant changes in the sagittal plane kinematics for ankle, knee and hip would occur. We feel that it is incomplete however to analyze changes in sEMG signals without taking kinematics in consideration. It is true that AFOs reduce the opportunity of changes in kinematics and reduce the muscle activity of some muscles. However, our data still shows muscle activity of the tibialis anterior muscle in the affected leg while wearing an AFO. Most patients wore a dynamic AFO, which does allow some movement in the ankle joint. Besides, patients could have applied compensatory mechanisms in walking, e.g. changing step length or using circumduction, which would have led to changes in at least one of the three joints.

Also, it is unclear why hip extensor or abductor emg data were not included in this data set since they should be activated and fatigued by uphill walking.

It is true that it would have been valuable to include sEMG of the gluteus muscles. We did collect some information on hip extensors as the semitendinosus and biceps femoris muscles also extend the hip. Unfortunately, we could not use more than 16 sEMG sensors due to availability of equipment. A sentence has been added in the limitation section: ‘Also, it would have been valuable if more muscles could have been included in sEMG measurement, especially the gluteus muscles, as hip extension contributes to positive power during uphill walking.’

The article is presented in an intelligible fashion and is written in standard English, however, the authors should use people first language. Throughout the text they refer to children with cerebral palsy as ‘CP patients’. Ethical standards appear to have been met with informed consent and IRB approval.

You are right about people first language, thank you for the comment. ‘CP patients’ has been replaced by ‘children with CP’ throughout the text.

There are some problems with data availability. The supplementary data provided does not represent full disclosure of the data. Only a single, normalized mean was provided as kinematic data for each participant for each condition. Presumably hundreds of steps were included in creating that mean, however no individual step data is provided and it is unknown how many steps were considered valid for each participant.

A table with the number of gait cycles per patient per condition has been added in Appendix S3 (see above). Also the individual kinematic data have been uploaded as Supplementary data (Zip files with Excel files per patient per condition).

EMG data were not accessible by this reviewer in the .sav file extension format. This was unreadable in wordpad or textedit. Is it possible to make the supplementary data more easily accessible to a wide variety of readers?

Sorry for the inconvenience. The EMG data was first provided in SPSS files, this has been changed to xlsx files (Excel).

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Xin Ye

22 Nov 2022

Lower limb muscle fatigue after uphill walking in children with unilateral spastic cerebral palsy

PONE-D-22-21864R1

Dear Dr. Moll,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Xin Ye, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Congratulations on a well presented study. The authors have addressed my concerns and I believe the paper adds to our understanding of fatigue among children with cerebral palsy.

Reviewer #2: thank you for attention to details and responding to all reviewer questions in a thoughtful and transparent manner

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mary E Gannotti

Reviewer #2: No

**********

Acceptance letter

Xin Ye

28 Nov 2022

PONE-D-22-21864R1

Lower limb muscle fatigue after uphill walking in children with unilateral spastic cerebral palsy

Dear Dr. Moll:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Xin Ye

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Text. This file contains all the supporting tables and figures.

    (DOCX)

    S1 Data

    (XLSX)

    S1 File

    (ZIP)

    S2 File

    (ZIP)

    S3 File

    (ZIP)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES